(Q40659544)

22 September 2017

title

C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina (English)

1 reference

22 September 2017

1 reference

coronary artery disease

1 reference

James S Zebrack

1

1 reference

22 September 2017

Joseph B Muhlestein

2

1 reference

22 September 2017

Benjamin D Horne

3

1 reference

22 September 2017

Jeffrey L Anderson

4

1 reference

22 September 2017

Intermountain Heart Collaboration Study Group

5

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Journal of the American College of Cardiology

22 September 2017

published in

1 reference

22 September 2017

volume

39

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

632-637

1 reference

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

Independent prognostic value of elevated C-reactive protein in unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Q-wave myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise tests

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction: missed opportunities for prevention?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901804-6

7 January 2021

10.1016/S0735-1097(01)01804-6

Identifiers

DOI

1 reference

22 September 2017

1 reference